Western blot analysis of two independent lymphoma cell lines confirmed that all sgRNAs caused a substantial increase in BCL-2 expression, detectable even before puromycin selection of sgRNA-transduced cells (Fig. 1b and Supplementary Fig. 1b). The gene discussed is BCL2; the disease is lymphoma.